Stefania Pipitone
Modena, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study.
Journal: Frontiers in oncology
Published: November 25, 2025
Future directions for antibody-drug conjugates in urothelial cancer.
Journal: Expert review of anticancer therapy
Published: November 20, 2025
Molecular Landscape of Advanced Endometrial Cancer: Exploratory Analyses at Modena Cancer Center (MEMO).
Journal: International journal of molecular sciences
Published: November 11, 2025
Adverse event profile following maintenance olaparib in patients with BRCA-mutated platinum-sensitive relapsed serous ovarian cancer in the phase III SOLO2 trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: October 16, 2025
Extravasation of enfortumab vedotin: a case report and literature review on antibody-drug conjugates.
Journal: European journal of hospital pharmacy : science and practice
Published: August 29, 2024
New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives.
Journal: International journal of molecular sciences
Published: August 07, 2024
A Novel Molecular Profile of Hormone-Sensitive Prostate Cancer Defines High Risk Patients.
Journal: Cancer medicine
Published: July 08, 2024
Homologous Recombination Repair Deficiency in Metastatic Prostate Cancer: New Therapeutic Opportunities.
Journal: International journal of molecular sciences
Published: March 25, 2024
Long-term responders to nivolumab in previously treated advanced renal cell carcinoma: a sub-analysis of meet-URO15 study.
Journal: Cancer immunology, immunotherapy : CII
Published: February 25, 2024
Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer.
Journal: Cancer treatment reviews
Published: January 12, 2024
Sodium levels and immunotherapy efficacy in mRCC patients with bone metastases: sub analysis of Meet-Uro 15 study.
Journal: Frontiers in immunology
Published: December 24, 2023
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study.
Journal: European urology
Published: December 04, 2023
Last Updated: 09/26/2026